PMEF
DCPH

Point72 Middle East FZE’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Point72 Middle East FZE’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,355
Closed -$310K – 1957
2023
Q3 		$310K Buy
+24,355
New +$336K 0.01% 924
2023
Q1 		– Sell
-9,276
Closed -$152K – 2339
2022
Q4 		$152K Buy
+9,276
New +$151K 0.01% 1144

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Middle East FZE's DCPH Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2023, closing a stake of 24,355 shares — an estimated $310K sold.

Point72 Middle East FZE first reported a position in DCPH in Q4 2022 and held it in 2 quarters. The position peaked at $310K in Q3 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 24,355 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $310K.
  • Point72 Middle East FZE first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $310K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.